Compare WHWK & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHWK | PLBY |
|---|---|---|
| Founded | 2007 | 1953 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 204.4M |
| IPO Year | N/A | 2020 |
| Metric | WHWK | PLBY |
|---|---|---|
| Price | $4.10 | $1.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.50 | $3.00 |
| AVG Volume (30 Days) | 317.4K | ★ 1.0M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,928,000.00 |
| Revenue This Year | N/A | $9.17 |
| Revenue Next Year | N/A | $7.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.13 |
| 52 Week Low | $1.57 | $1.19 |
| 52 Week High | $5.50 | $2.75 |
| Indicator | WHWK | PLBY |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 31.23 |
| Support Level | $3.72 | N/A |
| Resistance Level | $4.38 | $1.94 |
| Average True Range (ATR) | 0.35 | 0.13 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 23.56 | 10.79 |
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.